Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection-Reference-Cited by-同舟云学术

Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection

Published:2015-12-15 Issue:12 Volume:163 Page:899-907
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Kohli Anita¹,Kattakuzhy Sarah¹,Sidharthan Sreetha¹,Nelson Amy¹,McLaughlin Mary¹,Seamon Cassie¹,Wilson Eleanor¹,Meissner Eric G.¹,Sims Zayani¹,Silk Rachel¹,Gross Chloe¹,Akoth Elizabeth¹,Tang Lydia¹,Price Angie¹,Jolley Tim A.¹,Emmanuel Benjamin¹,Proschan Michael¹,Teferi Gebeyehu¹,Chavez Jose¹,Abbott Stephen¹,Osinusi Anuoluwapo¹,Mo Hongmei¹,Polis Michael A.¹,Masur Henry¹,Kottilil Shyam¹

Affiliation:

1. From National Institutes of Health Clinical Center, National Institute of Allergy and Infectious Diseases, and National Cancer Institute, Bethesda, Maryland; Institute of Human Virology, University of Maryland, Baltimore, Maryland; Medical University of South Carolina, Charleston, South Carolina; Unity Health Care, Washington, DC; and Gilead Sciences, Foster City, California.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Intervention of Serine Protease Inhibitors against Hepatitis C Virus;Current Medicinal Chemistry;2023-10-19

2. Shorter Duration Hepatitis C Virus Treatment is Associated with Better Persistence to Prescription Refills in People Who Inject Drugs: A Real-World Study;Advances in Therapy;2023-06-07

3. Second-Phase Hepatitis C Plasma Viral Kinetics Directly Reflects Reduced Intrahepatic Burden of Hepatitis C Virus;The Journal of Infectious Diseases;2023-02-01

4. Four Weeks Treatment with Glecaprevir/Pibrentasvir + Ribavirin—A Randomized Controlled Clinical Trial;Viruses;2022-03-16

5. Evaluation of cure rate in patients with hepatitis C virus completing shortened courses of treatment;Journal of the American Pharmacists Association;2022-01